术前CA 15-3和CEA水平在接受托瑞米芬治疗的管腔型可手术乳腺癌患者中的预后价值
Zhongshan Daxue xuebao. Yixue kexue ban, 2016 【目的】为了探讨在使用托瑞米芬治疗的管腔型可手术早期乳腺癌患者中，术前CA15-3及CEA水平与预后相关性。【方法】共纳入368名于2000年至2009年在本中心使用托瑞米芬进行辅助内分泌治疗的早期乳腺癌患者。使用卡方检验或Fisher检验进行分类变量的比较，使用Kaplan-Meier曲线描述无病生存期（DFS）和总生存期（OS），同时应用log-rank检验比较差异，并使用单因素及多因素Cox回归分析和分层分析法来寻找和DFS及OS相关的预后指标。【结果】在这368例患者中 ...
夏雯
doaj
FTO, PIK3CB serve as potential markers to complement CEA and CA15-3 for the diagnosis of breast cancer. [PDF]
Medicine (Baltimore), 2023 Mi J, Zhang H, Cao W, Yuan C.
europepmc +1 more source
Diagnostic value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural effusions [PDF]
, 2017 Introduction: Pleural effusion diagnosis plays an important role in determining treatment strategies. The aim of this study was to determine the diagnostic capacity of tumor markers CA 15-3 and NSE solely or in combination in differentiating the nature ...
Ehteram, H. +4 more
core
Dual-Channel Detection of Breast Cancer Biomarkers CA15-3 and CEA in Human Serum Using Dialysis-Silicon Nanowire Field Effect Transistor. [PDF]
Int J Nanomedicine, 2022 Li H +5 more
europepmc +1 more source
The Analysis of E-Cadherin, N-Cadherin, Vimentin, HER-2, CEA, CA15-3 and SF Expression in the Diagnosis of Canine Mammary Tumors. [PDF]
Animals (Basel), 2022 Yu C, Zheng H, Liu X, Xie G.
europepmc +1 more source
Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer. [PDF]
Dis Markers, 2021 Zhao W +7 more
europepmc +1 more source
血清CA15-3、CA125、CEA检测在乳腺癌诊断中的临床意义
Zhongguo shiyan zhenduanxue, 2011 目的探讨血清中CA15-3、CA125、CEA浓度在乳腺癌诊断中的临床意义。方法以乳腺癌患者76例、乳腺良性疾病患者58例、健康对照60例样本为试验材料,采用电化学发光免疫分析法检测血清中CA15-3、CA125、CEA浓度。结果乳腺癌组中血清CA15-3、CA125、CEA浓度均显著高于乳腺良性疾病患者和健康对照组 ...
张璞
doaj
Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis. [PDF]
Dis Markers, 2022 Xu J +5 more
europepmc +1 more source
Diagnostic Value of Dynamic Enhanced Magnetic Resonance Imaging Combined with Serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer. [PDF]
J Healthc Eng, 2022 Xue F, Meng Y, Jiang J.
europepmc +1 more source